This board is for fundamental and technical discussion about King Pharmaceuticals, Inc., KG.
KG is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The Company operates through five segments: Branded pharmaceuticals, Meridian Medical Technologies, Royalties, Contract manufacturing and other. On February 26, 2007, the Company acquired all the rights to Avinza in the United States, its territories and Canada from Ligand Pharmaceuticals Incorporated. In February 2007, King announced that the United States Food and Drug Administration approval of its manufacturing and production facility in Rochester, Michigan, for its Bicillin product line. On January 9, 2007, king obtained a license to the hemostatic products designed for use outside of catheterization and electrophysiology laboratories by Vascular Solutions, Inc. On March 1, 2006, it acquired substantially all of the assets of Allerex Laboratory LTD.
Weekly Five-Year Charts
Daily Nine-Month Charts